Oppilan Pharma Ltd — Form D
Oppilan Pharma Ltd of ALTRINCHAM, X0, a company, filed a Form D exempt-offering notice with the SEC on 2016-12-30. The offering totals $12.0M, of which $4.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-12-30
- Form: D
- Accession: 0001693601-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $4.3M
- Remaining: $7.8M
- Investors: 5
- Date of first sale: 2016-12-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-277436
Issuer
- Name: Oppilan Pharma Ltd
- CIK: 0001693601
- Entity type: Corporation
- Jurisdiction: UNITED KINGDOM
- Incorporated: 2015
- Address: 3RD FLOOR, ALTRINCHAM, X0, WA14 2DT
- Phone: 858-945-2393
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Christopher Krueger | Director | Nijmegen, P7 |
| Raju Mohan | Director | San Diego, CA |
| Christopher Krueger | Executive Officer | Nijmegen, P7 |
More